Search

everythinglearnresearchcommunity

for

Search:↓

Topical melatonin may reduce skin aging by inhibiting certain cellular pathways.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Topical rapamycin may effectively treat fibrous papules on the face.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Some medications can cause acne, and stopping these drugs is the main treatment.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

The framework suggests sun protection, retinoids, and antioxidants to improve skin longevity.

Dermatology drug use in Denmark mostly follows expected patterns, but further checks are needed for any misuse.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Most dermatology drugs in Denmark are used correctly, with few unusual patterns.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Nanoethosomes can improve the skin penetration of Lidocaine for topical use.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Transplant patients often get skin problems, with treatments varying by condition.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.